Drugs / eOCT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06400862 | Feb 2024 → Jun 2026 overdue | — | Chinese University of Hong Kong | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | eOCT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06400862 ↗ |
| Modality | Cell therapy | “bone marrow aspiration will be conducted to harvest autologous bone marrow for mesenchymal stem/stromal cells (MSCs) isolation for subsequent eOCT manufacturing” NCT06400862 ↗ |
| Route | Other | “delivering eOCT through arthroscopic surgery” NCT06400862 ↗ |